tirzepatide midvale ut Flex-Dose 1 mL Injectable 10 mg/mL Tirzepatide & Semaglutide Weight Loss

Non-Alcoholic Steatohepatitis (NASH) or Metabolic Dysfunction-Associated Steatohepatitis (MASH) : A more serious form with liver inflammation, scarring, and links to heart and kidney issues

With the rise of incretin therapies, two names have emerged as leaders: tirzepatide and semaglutide

At maximum doses, the two medications now produce very similar results: Wegovy 7.2 mg: 20.7% average weight loss (STEP UP trial) 2 Mounjaro 15 mg: 20.2% average weight loss (SURMOUNT-5 trial) 1 This means that if maximum weight loss is your primary goal, both medications can now achieve comparable results when used at their highest doses

Sticking to a routine is key